Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion

PLoS One. 2020 Dec 3;15(12):e0241500. doi: 10.1371/journal.pone.0241500. eCollection 2020.

Abstract

The presence of ascites in the peritoneal cavity leads to morphological and functional changes of the peritoneal mesothelial cell layer. Cells loose cell-cell interactions, rearrange their cytoskeleton, activate the production of fibronectin, and change their cell surface morphology in a proinflammatory environment. Moreover, ovarian cancer cell adhesion has been shown to be facilitated by these changes due to increased integrin- and CD44-mediated binding sites. In this study, the biological responsiveness of the human pleural mesothelial cell line MeT-5A to patient-derived and artificial ascites was studied in vitro and adhesion of ovarian cancer cells, i.e. SKOV-3 cells, investigated. Changes were mainly observed in cells exposed to artificial ascites containing higher cytokine concentrations than patient-derived ascites. Interestingly, reduced cell-cell interactions were already observed in untreated MeT-5A cells and effects on tight junction protein expression and permeability upon exposure to ascites were minor. Ascites induced upregulation of CDC42 effector protein 2 expression, which affects stress fiber formation, however significant F-actin reorganization was not observed. Moreover, fibronectin production remained unchanged. Analysis of mesothelial cell surface characteristics showed upregulated expression of intercellular adhesion molecule 1, slightly increased hyaluronic acid secretion and decreased microvillus expression upon exposure to ascites. Nevertheless, the observed changes were not sufficient to facilitate adhesion of SKOV-3 cells on MeT-5A cell layer. This study revealed that MeT-5A cells show a reduced biological responsiveness to the presence of ascites, in contrast to published studies on primary human peritoneal mesothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ascites / metabolism
  • Ascites / pathology
  • Cell Adhesion / drug effects*
  • Cell Line, Tumor
  • Cytokines / metabolism
  • Cytokines / pharmacology*
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Hyaluronan Receptors / genetics
  • Integrin beta1 / genetics
  • Intercellular Adhesion Molecule-1 / genetics
  • Neoplasms, Mesothelial / drug therapy*
  • Neoplasms, Mesothelial / genetics
  • Neoplasms, Mesothelial / metabolism
  • Neoplasms, Mesothelial / pathology
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology
  • Patients
  • Peritoneum / chemistry
  • Peritoneum / metabolism
  • Signal Transduction / genetics
  • cdc42 GTP-Binding Protein / genetics

Substances

  • CD44 protein, human
  • Cytokines
  • Hyaluronan Receptors
  • ICAM1 protein, human
  • Integrin beta1
  • Intercellular Adhesion Molecule-1
  • cdc42 GTP-Binding Protein

Grants and funding

V.H.-S. and B.R.-R. are grant recipients of the Swiss national science foundation (grant number: CRSII5_171037); URL: http://www.snf.ch/en/funding/programmes/sinergia/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A.P.-F. and B.R.-R. received funding for the study from the Adolphe Merkle Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.